.


:




:

































 

 

 

 


()(15- 19)




- 㳿, , .

˳

1. .

):

- : 2 / ,

- ( , ): 50 ,

)

- - 2 :

( ) 7,5-1,5 /,

ͳ( ) 100 ,

() 200 1-2 ;

- :

( ) 100-150 /;

( ) 150 /;

.

dz 1 . 2 /

ij 50 2 /

) ﳿ:

- 2-3 3 .

- 5 . 3 / 2-3 3 . 3/ .

) ( , 4 풺 ).

- ( 20-40 ),

- 2 .

2. ( 䳿):

) :

- () 500 2 6 ,

- () 500-1500 1 2-3 ,

- .

)

- () 20 1 , 3 ,

3. ̳ .

4. , :

- ( , ) 100 3 ,

- () 75 /

5. :

) :

- 쳿 糿 ,

) IV :

-

- .

6. ˳ .

7. Գ .

8. .

 

 

:

Ø ³ , .

Ø .

Ø , ( , ).

 

:

, , .

, - , , - , , .

, , - , (hallux valgus) , , V , .

 

:

ESCISIT EULAR Standing Committa for International clinical Studies Including Therapeutics (2003)

/
1. ;
2. : ) (, , , ); ) (, , ); ) ; ) ; ) ;
3. , , ( .), .
4. ( 4/ ) 糿.
5. . 2().
6. , / , , .
7. (, , , ,, .
8. , / , .
9. , 糿 / , , , , .
10. .

 

:

ESCISIT EULAR Standing Committa for International clinical Studies Including Therapeutics (2004)

/
1. ;
2. : ) (, , , ); ) (, , ); ) ; ) ; ) ;
3. , , ( .), .
4. 䳿.
5. ﳿ( , ).
6. . 2- .
7. , / , .
8. ( , .) .
9. / , , .
10. .

:

. (, , , );

1. .

2. ij , (, - ).

3. .

. ( ).

:

. :

1. ;

2. ;

3. ;

. :

1. ;

2. 12 ;

3. 3 ;

. ?

1. , , ;

2. ;

:

1.

2. ,

IV. :

1.;
2. ;

3. , .

V. , :

1. Vite;

2. , .

3. .

V. :

1. ;

2. .

V. :

1. ;

2. ;

3. , .

V. ϳ :

1. ;

2. ;

3. ;

4. ;

5. ʳ

V. ?

1. ;

2. ;

3. .;

4. ;

5.

. ?

1. ;

2. ;

3. ;

4. ;

5. .

. , ?

1. ;

2. ;

3.;

4.;

5. .

ղ. ?

1. ;

2. ;

3. ;

4. ;

5. ( )

ղ. ?

1. ;

2. ;

3. ;

4. ;

5. .

. ?

1. ;

2. ;

3. ;

4. ;

5. ;

ղV. ?

1. ;
2. ;

3. ;
4.;

5. .

ղV. :

1. ;

2.;

3.;

4. ;

5. '.

 

 

:

:

1. .. , .. , .. , .. . . : - ȯ - 2006. . 277-330

2. ,, . ϳ , . .. , . .. -2004 . 95-132.

3. .. .. . ȯ 2003-447.

:

1. . ϳ . .. , , 2003, 506

2. . . . .

.. .. , 201 -19-58,88 -2008.

1. .. . // . 2004. . 13. 8. . 57-63.
2. ., . . : , 1993. 321 .
3. . : . . .: -McGraw-Hill, 1999. 459 .
4. Jang D., Sellors J., Howard M. et al. Correlation between culture testing of swabs and ligase chain reaction of first void urine from patients recently treated for Chlamydia trachomatis. Sex Transm Infect 2003; 79: 237-9.
5. Kinnunen A., Molander P., Morrison R. et al. Chlamydial heat shock protein 60-specific T cells in inflamed salpingeal tissue. Fertil Steril 2002; 77: 162-6.
6. Lyss S.B., Kamb M.L., Peterman T.A. et al. Chlamydia trachomatis among patients infected with and treated for Neisseria gonorrhoeae in sexually transmitted disease clinics in the United States. Ann Intern Med 2003; 139: 178-85.
7. Misyurina O.Y., Chipitsyna E.V., Finashutina Y.P. et al. Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides. Antimicrob Agents Chemother 2004; 48 (4): 1347-9.
8. Morrison S.G., Morrison R.P. Resolution of secondary Chlamydia trachomatis genital tract infection in immune mice with depletion of both CD4+ and CD8+ T cells. Infect Immun 2001; 69 (4): 2643-9.
9. Rich E., Hook III E.W., Alarcon G.S., Moreland L.W. Reactive arthritis in patients attending an urban sexually transmitted diseases clinic. Arthr Rheum 1996; 39: 1172-7.
10. Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 2002; 51 (RR-6): 1-78.
11. Somani J., Bhullar V.B., Workowski K.A. et al. Multiple drug-resistant Chlamydia trachomatis associated with clinical treatment failure. J Infect Dis 2000; 181: 1421-7.
12. Stamm W.E., Holmes K.K. Chlamydia trachomatis infections in adults. In Holmes K.K., Mardh P.A., Sparling P.F., Weisner P.J. eds. Sexually Transmitted Diseases. New York: McGraw Hill International, 1999.
13. Stephens R.S., Kalman S., Lammel C. et al. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 1998; 282: 754-9.
14. Toivanen A. Reactive arthritis and Reiters syndrome: history and clinical features. In: Klippel J.H., Dieppe P.A. eds. Rheumatology Vol. 2 (6:11), 2nd Edn. London: Mosby, 1998: 1-8.
15. Whittington W.L., Kent C., Kissinger P. et al. Determinants of persistent and recurrent Chlamydia trachomatis infection in young women: results of a multicenter cohort study. Sex Transm Dis 2001; 28: 117-23.
16. Wyrick P.B., Knight S.T. Pre-exposure of infected human endometrial epithelial cells to penicillin in vitro renders Chlamydia trachomatis refractory to azithromycin. J Antimicrob Chemother 2004; 54 (1): 79-85.

 

 

..., ..

 





:


: 2015-09-20; !; : 656 |


:

:

.
==> ...

1915 - | 1798 -


© 2015-2024 lektsii.org - -

: 0.042 .